共 111 条
[1]
Soriguer F(2012)Prevalence of diabetes mellitus and impaired glucose regulation in Spain: the Di@bete.es study Diabetologia 55 88-93
[2]
Goday A(2010)Global healthcare expenditure on diabetes for 2010 and 2030 Diabetes Res Clin Pract 87 293-301
[3]
Bosch-Comas A(2003)Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes N Engl J Med 348 383-393
[4]
Zhang P(2008)Effect of a multifactorial intervention on mortality in type 2 diabetes N Engl J Med 358 580-591
[5]
Zhang X(2008)Cost-effectiveness of intensified versus conventional multifactorial intervention in type 2 diabetes: results and projections from the Steno-2 study Diabetes Care 31 1510-1515
[6]
Brown J(2006)Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes Diabetes Care 29 1963-1972
[7]
Gaede P(2006)The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes Lancet 368 1696-1705
[8]
Vedel P(2010)Liraglutide versus sitagliptin for patients with type 2 diabetes who did not have adequate glycaemic control with metformin: a 26-week, randomised, parallel-group, open-label trial Lancet 375 1447-1456
[9]
Larsen N(2004)The CORE Diabetes Model: projecting long-term clinical outcomes, costs and cost-effectiveness of interventions in diabetes mellitus (types 1 and 2) to support clinical and reimbursement decision-making Curr Med Res Opin 20 5-26
[10]
Jensen GV(2004)Validation of the CORE Diabetes Model against epidemiological and clinical studies Curr Med Res Opin 20 27-40